BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiao Y, Song C, Lin Q, Shi X, Yu W, Huang X, Wang H, Chen Y, Wang R, Geng X, Qin M, Hu K, Fan Y, Qiao Y, Gao E, Zhao W, Chang J. Cardioprotection of (±)-sodium 5-bromo-2-(α-hydroxypentyl) benzoate (BZP) on mouse myocardium I/R injury through inhibiting 12/15-LOX-2 activity. Journal of Molecular and Cellular Cardiology 2019;135:52-66. [DOI: 10.1016/j.yjmcc.2019.07.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Lagoutte-Renosi J, Allemand F, Ramseyer C, Yesylevskyy S, Davani S. Molecular modeling in cardiovascular pharmacology: Current state of the art and perspectives. Drug Discov Today 2021:S1359-6446(21)00533-X. [PMID: 34863931 DOI: 10.1016/j.drudis.2021.11.026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Zhang D, Wang Q, Qiu X, Chen Y, Yang X, Guan Y. Remifentanil protects heart from myocardial ischaemia/reperfusion (I/R) injury via miR-206-3p/TLR4/NF-κB signalling axis. J Pharm Pharmacol 2021:rgab151. [PMID: 34850055 DOI: 10.1093/jpp/rgab151] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Marco-Contelles J, Zhang Y. From Seeds of Apium graveolens Linn. to a Cerebral Ischemia Medicine: The Long Journey of 3-n-Butylphthalide. J Med Chem 2020;63:12485-510. [PMID: 32672958 DOI: 10.1021/acs.jmedchem.0c00887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Gao Y, Cao X, Zhang X, Wang Y, Huang H, Meng Y, Chang J. Brozopine Inhibits 15-LOX-2 Metabolism Pathway After Transient Focal Cerebral Ischemia in Rats and OGD/R-Induced Hypoxia Injury in PC12 Cells. Front Pharmacol 2020;11:99. [PMID: 32153408 DOI: 10.3389/fphar.2020.00099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]